nodes	percent_of_prediction	percent_of_DWPC	metapath
Roxithromycin—CYP1A2—chronic obstructive pulmonary disease	0.566	1	CbGaD
Roxithromycin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.065	0.209	CbGbCtD
Roxithromycin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0529	0.17	CbGbCtD
Roxithromycin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0357	0.115	CbGbCtD
Roxithromycin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0341	0.11	CbGbCtD
Roxithromycin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0304	0.0978	CbGbCtD
Roxithromycin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0297	0.0958	CbGbCtD
Roxithromycin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0281	0.0905	CbGbCtD
Roxithromycin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0574	CbGbCtD
Roxithromycin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0168	0.0542	CbGbCtD
Roxithromycin—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.00401	0.0393	CcSEcCtD
Roxithromycin—Hepatitis cholestatic—Montelukast—chronic obstructive pulmonary disease	0.00359	0.0352	CcSEcCtD
Roxithromycin—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.0282	CcSEcCtD
Roxithromycin—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.0171	CcSEcCtD
Roxithromycin—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00172	0.0168	CcSEcCtD
Roxithromycin—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.0146	CcSEcCtD
Roxithromycin—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00145	0.0142	CcSEcCtD
Roxithromycin—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.0138	CcSEcCtD
Roxithromycin—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.00141	0.0138	CcSEcCtD
Roxithromycin—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00132	0.0779	CbGpPWpGaD
Roxithromycin—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.0126	CcSEcCtD
Roxithromycin—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0116	CcSEcCtD
Roxithromycin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0114	CcSEcCtD
Roxithromycin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.068	CbGpPWpGaD
Roxithromycin—Azithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.294	CrCbGaD
Roxithromycin—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0112	CcSEcCtD
Roxithromycin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0112	CcSEcCtD
Roxithromycin—Telithromycin—CYP1A2—chronic obstructive pulmonary disease	0.00112	0.286	CrCbGaD
Roxithromycin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.0105	CcSEcCtD
Roxithromycin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00102	0.0601	CbGpPWpGaD
Roxithromycin—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000926	0.00907	CcSEcCtD
Roxithromycin—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000926	0.00907	CcSEcCtD
Roxithromycin—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00905	CcSEcCtD
Roxithromycin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000913	0.00895	CcSEcCtD
Roxithromycin—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000911	0.00892	CcSEcCtD
Roxithromycin—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000911	0.00892	CcSEcCtD
Roxithromycin—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000907	0.00888	CcSEcCtD
Roxithromycin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000902	0.00883	CcSEcCtD
Roxithromycin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000898	0.0088	CcSEcCtD
Roxithromycin—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000889	0.00871	CcSEcCtD
Roxithromycin—Clarithromycin—CYP1A2—chronic obstructive pulmonary disease	0.000876	0.223	CrCbGaD
Roxithromycin—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000875	0.00856	CcSEcCtD
Roxithromycin—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00842	CcSEcCtD
Roxithromycin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000855	0.00837	CcSEcCtD
Roxithromycin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000836	0.0492	CbGpPWpGaD
Roxithromycin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000824	0.00807	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000802	0.00785	CcSEcCtD
Roxithromycin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000788	0.00772	CcSEcCtD
Roxithromycin—Erythromycin—CYP1A2—chronic obstructive pulmonary disease	0.000771	0.196	CrCbGaD
Roxithromycin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000765	0.00749	CcSEcCtD
Roxithromycin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00744	CcSEcCtD
Roxithromycin—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000759	0.00743	CcSEcCtD
Roxithromycin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000731	0.00716	CcSEcCtD
Roxithromycin—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000722	0.00708	CcSEcCtD
Roxithromycin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00071	0.00695	CcSEcCtD
Roxithromycin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000692	0.00678	CcSEcCtD
Roxithromycin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000687	0.00672	CcSEcCtD
Roxithromycin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000686	0.00672	CcSEcCtD
Roxithromycin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00066	0.00646	CcSEcCtD
Roxithromycin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00066	0.00646	CcSEcCtD
Roxithromycin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000654	0.00641	CcSEcCtD
Roxithromycin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000654	0.0064	CcSEcCtD
Roxithromycin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.00639	CcSEcCtD
Roxithromycin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00637	CcSEcCtD
Roxithromycin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000616	0.00604	CcSEcCtD
Roxithromycin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00597	CcSEcCtD
Roxithromycin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000602	0.00589	CcSEcCtD
Roxithromycin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00588	CcSEcCtD
Roxithromycin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00586	CcSEcCtD
Roxithromycin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00586	CcSEcCtD
Roxithromycin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00577	CcSEcCtD
Roxithromycin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00577	CcSEcCtD
Roxithromycin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00574	CcSEcCtD
Roxithromycin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000582	0.0057	CcSEcCtD
Roxithromycin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.0057	CcSEcCtD
Roxithromycin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00566	CcSEcCtD
Roxithromycin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000574	0.00563	CcSEcCtD
Roxithromycin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00554	CcSEcCtD
Roxithromycin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00545	CcSEcCtD
Roxithromycin—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000552	0.0054	CcSEcCtD
Roxithromycin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00538	CcSEcCtD
Roxithromycin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00538	CcSEcCtD
Roxithromycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.00536	CcSEcCtD
Roxithromycin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00532	CcSEcCtD
Roxithromycin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00532	CcSEcCtD
Roxithromycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00516	CcSEcCtD
Roxithromycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00516	CcSEcCtD
Roxithromycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00508	CcSEcCtD
Roxithromycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000516	0.00505	CcSEcCtD
Roxithromycin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00502	CcSEcCtD
Roxithromycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00051	0.00499	CcSEcCtD
Roxithromycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00487	CcSEcCtD
Roxithromycin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.00482	CcSEcCtD
Roxithromycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00479	CcSEcCtD
Roxithromycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.00471	CcSEcCtD
Roxithromycin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00464	CcSEcCtD
Roxithromycin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000473	0.00464	CcSEcCtD
Roxithromycin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00462	CcSEcCtD
Roxithromycin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00454	CcSEcCtD
Roxithromycin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00454	CcSEcCtD
Roxithromycin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00454	CcSEcCtD
Roxithromycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.00452	CcSEcCtD
Roxithromycin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000458	0.00448	CcSEcCtD
Roxithromycin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00445	CcSEcCtD
Roxithromycin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00437	CcSEcCtD
Roxithromycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00044	0.00431	CcSEcCtD
Roxithromycin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00429	CcSEcCtD
Roxithromycin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00428	CcSEcCtD
Roxithromycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00427	CcSEcCtD
Roxithromycin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00427	CcSEcCtD
Roxithromycin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00425	CcSEcCtD
Roxithromycin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00425	CcSEcCtD
Roxithromycin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00425	CcSEcCtD
Roxithromycin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00423	CcSEcCtD
Roxithromycin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000432	0.00423	CcSEcCtD
Roxithromycin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.025	CbGpPWpGaD
Roxithromycin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000422	0.0248	CbGpPWpGaD
Roxithromycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000418	0.0041	CcSEcCtD
Roxithromycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.0041	CcSEcCtD
Roxithromycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.00406	CcSEcCtD
Roxithromycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00403	CcSEcCtD
Roxithromycin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00403	CcSEcCtD
Roxithromycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000411	0.00403	CcSEcCtD
Roxithromycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00401	CcSEcCtD
Roxithromycin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00401	CcSEcCtD
Roxithromycin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.004	CcSEcCtD
Roxithromycin—CYP2B6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.0237	CbGpPWpGaD
Roxithromycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00387	CcSEcCtD
Roxithromycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.0038	CcSEcCtD
Roxithromycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000388	0.0038	CcSEcCtD
Roxithromycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.0038	CcSEcCtD
Roxithromycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00372	CcSEcCtD
Roxithromycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00365	CcSEcCtD
Roxithromycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00365	CcSEcCtD
Roxithromycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00359	CcSEcCtD
Roxithromycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00357	CcSEcCtD
Roxithromycin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00353	CcSEcCtD
Roxithromycin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00353	CcSEcCtD
Roxithromycin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000359	0.0211	CbGpPWpGaD
Roxithromycin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000357	0.0035	CcSEcCtD
Roxithromycin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00346	CcSEcCtD
Roxithromycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00345	CcSEcCtD
Roxithromycin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00341	CcSEcCtD
Roxithromycin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00341	CcSEcCtD
Roxithromycin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00334	CcSEcCtD
Roxithromycin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00333	CcSEcCtD
Roxithromycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00328	CcSEcCtD
Roxithromycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00328	CcSEcCtD
Roxithromycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00325	CcSEcCtD
Roxithromycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00325	CcSEcCtD
Roxithromycin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00325	CcSEcCtD
Roxithromycin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00325	CcSEcCtD
Roxithromycin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00323	CcSEcCtD
Roxithromycin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00323	CcSEcCtD
Roxithromycin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00322	CcSEcCtD
Roxithromycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00321	CcSEcCtD
Roxithromycin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.0192	CbGpPWpGaD
Roxithromycin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000325	0.0191	CbGpPWpGaD
Roxithromycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00319	CcSEcCtD
Roxithromycin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00318	CcSEcCtD
Roxithromycin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.00318	CcSEcCtD
Roxithromycin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00316	CcSEcCtD
Roxithromycin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.00313	CcSEcCtD
Roxithromycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.0031	CcSEcCtD
Roxithromycin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00309	CcSEcCtD
Roxithromycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00307	CcSEcCtD
Roxithromycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00307	CcSEcCtD
Roxithromycin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00307	CcSEcCtD
Roxithromycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00306	CcSEcCtD
Roxithromycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00306	CcSEcCtD
Roxithromycin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00305	CcSEcCtD
Roxithromycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000306	0.003	CcSEcCtD
Roxithromycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00289	CcSEcCtD
Roxithromycin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00288	CcSEcCtD
Roxithromycin—CYP2B6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.0172	CbGpPWpGaD
Roxithromycin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00284	CcSEcCtD
Roxithromycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.00279	CcSEcCtD
Roxithromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.0155	CbGpPWpGaD
Roxithromycin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00251	CcSEcCtD
Roxithromycin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.0148	CbGpPWpGaD
Roxithromycin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.0143	CbGpPWpGaD
Roxithromycin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00231	CcSEcCtD
Roxithromycin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.0023	CcSEcCtD
Roxithromycin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00227	CcSEcCtD
Roxithromycin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00224	CcSEcCtD
Roxithromycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00223	CcSEcCtD
Roxithromycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00222	CcSEcCtD
Roxithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.0129	CbGpPWpGaD
Roxithromycin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00209	CcSEcCtD
Roxithromycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00206	CcSEcCtD
Roxithromycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00203	CcSEcCtD
Roxithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.0121	CbGpPWpGaD
Roxithromycin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.0117	CbGpPWpGaD
Roxithromycin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.0116	CbGpPWpGaD
Roxithromycin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00193	CcSEcCtD
Roxithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.0114	CbGpPWpGaD
Roxithromycin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.0112	CbGpPWpGaD
Roxithromycin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00185	CcSEcCtD
Roxithromycin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.011	CbGpPWpGaD
Roxithromycin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00182	CcSEcCtD
Roxithromycin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0108	CbGpPWpGaD
Roxithromycin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00179	CcSEcCtD
Roxithromycin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00176	CcSEcCtD
Roxithromycin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00176	CcSEcCtD
Roxithromycin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00176	CcSEcCtD
Roxithromycin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00175	CcSEcCtD
Roxithromycin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.0104	CbGpPWpGaD
Roxithromycin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.0101	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000171	0.0101	CbGpPWpGaD
Roxithromycin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00167	CcSEcCtD
Roxithromycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00166	CcSEcCtD
Roxithromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00985	CbGpPWpGaD
Roxithromycin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00976	CbGpPWpGaD
Roxithromycin—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00972	CbGpPWpGaD
Roxithromycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00161	CcSEcCtD
Roxithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00936	CbGpPWpGaD
Roxithromycin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000153	0.00899	CbGpPWpGaD
Roxithromycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000153	0.0015	CcSEcCtD
Roxithromycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00144	CcSEcCtD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000145	0.00853	CbGpPWpGaD
Roxithromycin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00852	CbGpPWpGaD
Roxithromycin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00139	CcSEcCtD
Roxithromycin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00134	CcSEcCtD
Roxithromycin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000137	0.00804	CbGpPWpGaD
Roxithromycin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00798	CbGpPWpGaD
Roxithromycin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00783	CbGpPWpGaD
Roxithromycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00129	CcSEcCtD
Roxithromycin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00128	CcSEcCtD
Roxithromycin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00128	CcSEcCtD
Roxithromycin—Headache—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00127	CcSEcCtD
Roxithromycin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00754	CbGpPWpGaD
Roxithromycin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00753	CbGpPWpGaD
Roxithromycin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00121	CcSEcCtD
Roxithromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00716	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000121	0.00714	CbGpPWpGaD
Roxithromycin—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00706	CbGpPWpGaD
Roxithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00705	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000112	0.00657	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000111	0.00651	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000101	0.00593	CbGpPWpGaD
Roxithromycin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.86e-05	0.0058	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.41e-05	0.00554	CbGpPWpGaD
Roxithromycin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.41e-05	0.00554	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.87e-05	0.00522	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.86e-05	0.00521	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.86e-05	0.00521	CbGpPWpGaD
Roxithromycin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.86e-05	0.00521	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.73e-05	0.00514	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.68e-05	0.0051	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.63e-05	0.00508	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.58e-05	0.00504	CbGpPWpGaD
Roxithromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.29e-05	0.00487	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.14e-05	0.00479	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.78e-05	0.00458	CbGpPWpGaD
Roxithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.61e-05	0.00448	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.6e-05	0.00447	CbGpPWpGaD
Roxithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.00442	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.26e-05	0.00427	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.22e-05	0.00424	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00424	CbGpPWpGaD
Roxithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.16e-05	0.00421	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.00418	CbGpPWpGaD
Roxithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.00416	CbGpPWpGaD
Roxithromycin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.84e-05	0.00402	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.73e-05	0.00396	CbGpPWpGaD
Roxithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.17e-05	0.00363	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.05e-05	0.00356	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.01e-05	0.00354	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.00349	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.81e-05	0.00342	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.66e-05	0.00333	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.56e-05	0.00327	CbGpPWpGaD
Roxithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.53e-05	0.00325	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.00325	CbGpPWpGaD
Roxithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.00321	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.00321	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.00308	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.00304	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.11e-05	0.003	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.05e-05	0.00297	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.9e-05	0.00288	CbGpPWpGaD
Roxithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.00264	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.22e-05	0.00248	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.15e-05	0.00244	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.15e-05	0.00244	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.98e-05	0.00234	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.94e-05	0.00232	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.9e-05	0.00229	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.9e-05	0.00229	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.81e-05	0.00224	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.74e-05	0.0022	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.74e-05	0.0022	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.59e-05	0.00211	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.56e-05	0.00209	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.56e-05	0.00209	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.54e-05	0.00208	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.00205	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.37e-05	0.00198	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.00193	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.25e-05	0.00191	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.0019	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.00189	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.11e-05	0.00183	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.1e-05	0.00182	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.00181	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00179	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.89e-05	0.0017	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.00164	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.73e-05	0.00161	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-05	0.0016	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.00159	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.53e-05	0.00149	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.00148	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.48e-05	0.00146	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.00146	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.0014	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00138	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.00121	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.00118	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.92e-05	0.00113	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.0011	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.77e-05	0.00104	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.66e-05	0.000979	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.64e-05	0.000967	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.6e-05	0.000941	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.6e-05	0.000939	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.53e-05	0.000899	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.000881	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.49e-05	0.000874	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.48e-05	0.000873	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000863	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.43e-05	0.000839	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000787	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.000746	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.26e-05	0.00074	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.000726	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.000725	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000697	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000675	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000644	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000636	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000605	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.000597	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.87e-06	0.000581	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.59e-06	0.000564	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.45e-06	0.000556	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.1e-06	0.000535	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.96e-06	0.000527	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.74e-06	0.000514	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.64e-06	0.000508	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.05e-06	0.000474	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.88e-06	0.000463	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.59e-06	0.000446	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.48e-06	0.00044	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.97e-06	0.00041	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.74e-06	0.000397	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.67e-06	0.000392	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.61e-06	0.000389	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.09e-06	0.000358	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.08e-06	0.000358	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.06e-06	0.000356	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.97e-06	0.000351	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.83e-06	0.000343	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.6e-06	0.00033	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.57e-06	0.000327	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.28e-06	0.00031	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.67e-06	0.000275	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.61e-06	0.000271	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	0.000264	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.3e-06	0.000253	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.3e-06	0.000253	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.07e-06	0.000239	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.59e-06	0.000211	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.43e-06	0.000202	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.77e-06	0.000163	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-06	0.000156	CbGpPWpGaD
